These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 27132720)

  • 1. Insight into the Structural Requirements of Theophylline-Based Aldehyde Dehydrogenase lAl (ALDHlAl) Inhibitors Through Multi-QSAR Modeling and Molecular Docking Approaches.
    Abdul Amin S; Adhikari N; Gayen S; Jha T
    Curr Drug Discov Technol; 2016; 13(2):84-100. PubMed ID: 27132720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of NCT-501, a Potent and Selective Theophylline-Based Inhibitor of Aldehyde Dehydrogenase 1A1 (ALDH1A1).
    Yang SM; Yasgar A; Miller B; Lal-Nag M; Brimacombe K; Hu X; Sun H; Wang A; Xu X; Nguyen K; Oppermann U; Ferrer M; Vasiliou V; Simeonov A; Jadhav A; Maloney DJ
    J Med Chem; 2015 Aug; 58(15):5967-78. PubMed ID: 26207746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D-QSAR and scaffold hopping based designing of benzo[d]ox-azol-2(3H)-one and 2-oxazolo[4,5-b]pyridin-2(3H)-one derivatives as selective aldehyde dehydrogenase 1A1 inhibitors: Synthesis and biological evaluation.
    Verma H; Narendra G; Raju B; Kumar M; Jain SK; Tung GK; Singh PK; Silakari O
    Arch Pharm (Weinheim); 2022 Sep; 355(9):e2200108. PubMed ID: 35618489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors.
    Morgan CA; Hurley TD
    J Med Chem; 2015 Feb; 58(4):1964-75. PubMed ID: 25634381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a high-throughput in vitro assay to identify selective inhibitors for human ALDH1A1.
    Morgan CA; Hurley TD
    Chem Biol Interact; 2015 Jun; 234():29-37. PubMed ID: 25450233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition.
    Kulsum S; Sudheendra HV; Pandian R; Ravindra DR; Siddappa G; R N; Chevour P; Ramachandran B; Sagar M; Jayaprakash A; Mehta A; Kekatpure V; Hedne N; Kuriakose MA; Suresh A
    Mol Carcinog; 2017 Feb; 56(2):694-711. PubMed ID: 27380877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple machine learning models combined with virtual screening and molecular docking to identify selective human ALDH1A1 inhibitors.
    Narendra G; Raju B; Verma H; Sapra B; Silakari O
    J Mol Graph Model; 2021 Sep; 107():107950. PubMed ID: 34089986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined 2D and 3D-QSAR, molecular modelling and docking studies of pyrazolodiazepinones as novel phosphodiesterase 2 inhibitors.
    Bhansali SG; Kulkarni VM
    SAR QSAR Environ Res; 2014; 25(11):905-37. PubMed ID: 25401514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined HQSAR, topomer CoMFA, homology modeling and docking studies on triazole derivatives as SGLT2 inhibitors.
    Yu S; Yuan J; Zhang Y; Gao S; Gan Y; Han M; Chen Y; Zhou Q; Shi J
    Future Med Chem; 2017 Jun; 9(9):847-858. PubMed ID: 28635308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of aldehyde dehydrogenases of the 1A subfamily as putative anticancer agents: Kinetic characterization and effect on human cancer cells.
    Jiménez R; Pequerul R; Amor A; Lorenzo J; Metwally K; Avilés FX; Parés X; Farrés J
    Chem Biol Interact; 2019 Jun; 306():123-130. PubMed ID: 30958995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural, Biochemical, and Computational Studies Reveal the Mechanism of Selective Aldehyde Dehydrogenase 1A1 Inhibition by Cytotoxic Duocarmycin Analogues.
    Koch MF; Harteis S; Blank ID; Pestel G; Tietze LF; Ochsenfeld C; Schneider S; Sieber SA
    Angew Chem Int Ed Engl; 2015 Nov; 54(46):13550-4. PubMed ID: 26373694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the relationship of anthranilic derivatives structure and the FXR (Farnesoid X receptor) agonist activity.
    Kronenberger T; Windshügel B; Wrenger C; Honorio KM; Maltarollo VG
    J Biomol Struct Dyn; 2018 Dec; 36(16):4378-4391. PubMed ID: 29237358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First report on exploring structural requirements of α and β thymidine analogs for PfTMPK inhibitory activity using in silico studies.
    Ojha PK; Roy K
    Biosystems; 2013 Sep; 113(3):177-95. PubMed ID: 23850534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a 96-well cellular assay for the discovery of ALDH1A1 inhibitors.
    Ming W; Ma W; Chen LH; Volk C; Michael MD; Xu Y; Zhang F; Wang X
    Assay Drug Dev Technol; 2013 Jul; 11(6):388-95. PubMed ID: 23957476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA.
    Sainy J; Sharma R
    SAR QSAR Environ Res; 2015; 26(10):873-92. PubMed ID: 26524489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
    AbdulHameed MD; Hamza A; Liu J; Zhan CG
    J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple molecular modelling studies on some derivatives and analogues of glutamic acid as matrix metalloproteinase-2 inhibitors.
    Jha T; Adhikari N; Saha A; Amin SA
    SAR QSAR Environ Res; 2018 Jan; 29(1):43-68. PubMed ID: 29254380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A High-Content Assay Enables the Automated Screening and Identification of Small Molecules with Specific ALDH1A1-Inhibitory Activity.
    Yasgar A; Titus SA; Wang Y; Danchik C; Yang SM; Vasiliou V; Jadhav A; Maloney DJ; Simeonov A; Martinez NJ
    PLoS One; 2017; 12(1):e0170937. PubMed ID: 28129349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined 3D-QSAR modeling and molecular docking study on 1,4-dihydroindeno[1,2-c]pyrazoles as VEGFR-2 kinase inhibitors.
    Zeng H; Zhang H
    J Mol Graph Model; 2010 Aug; 29(1):54-71. PubMed ID: 20471293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative QSAR study using CoMFA, HQSAR, and FRED/SKEYS paradigms for estrogen receptor binding affinities of structurally diverse compounds.
    Waller CL
    J Chem Inf Comput Sci; 2004; 44(2):758-65. PubMed ID: 15032558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.